Evidence map›Paper›PMID 24152729›Full record

ArticleMolecular biology of the cell2013

Stathmin and microtubules regulate mitotic entry in HeLa cells by controlling activation of both Aurora kinase A and Plk1.

Victoria C Silva, Lynne Cassimeris

Abstract read
In one paragraph

Article in Molecular biology of the cell, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it, 28 citations in OpenAlex.

  1. [Prognostic Value of STMN1 Expression in Non-small Cell Lung Cancer: 
A Meta-analysis].Zhongguo fei ai za zhi = Chinese journal of lung cancer · 2024
    Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Victoria C SilvaDepartment of Biological Sciences, Lehigh University, Bethlehem, PA 18015.
Lynne Cassimeris
Lehigh University · US

Funding

Signal Transduction by the Microtubule Destabilizer, Stathmin/Oncoprotein 18R15GM100381 · NIGMS · LEHIGH UNIVERSITY · PI CASSIMERIS, LYNNE · 2012 to 2012
$365k
NIGMS NIH HHS R15 GM100381
6 · The paper itself

Abstract

Depletion of stathmin, a microtubule (MT) destabilizer, delays mitotic entry by ∼4 h in HeLa cells. Stathmin depletion reduced the activity of CDC25 and its upstream activators, Aurora A and Plk1. Chemical inhibition of both Aurora A and Plk1 was sufficient to delay mitotic entry by 4 h, while inhibiting either kinase alone did not cause a delay. Aurora A and Plk1 are likely regulated downstream of stathmin, because the combination of stathmin knockdown and inhibition of Aurora A and Plk1 was not additive and again delayed mitotic entry by 4 h. Aurora A localization to the centrosome required MTs, while stathmin depletion spread its localization beyond that of γ-tubulin, indicating an MT-dependent regulation of Aurora A activation. Plk1 was inhibited by excess stathmin, detected in in vitro assays and cells overexpressing stathmin-cyan fluorescent protein. Recruitment of Plk1 to the centrosome was delayed in stathmin-depleted cells, independent of MTs. It has been shown that depolymerizing MTs with nocodazole abrogates the stathmin-depletion induced cell cycle delay; in this study, depolymerization with nocodazole restored Plk1 activity to near normal levels, demonstrating that MTs also contribute to Plk1 activation. These data demonstrate that stathmin regulates mitotic entry, partially via MTs, to control localization and activation of both Aurora A and Plk1.

Indexed as

Aurora Kinase Acdc25 PhosphatasesCDC2 Protein KinaseCell Cycle ProteinsCell Line, TumorCentrosomeCyclin BG2 Phase Cell Cycle CheckpointsHeLa CellsHumansMicrotubulesMitosisNocodazolePolo-Like Kinase 1Protein Serine-Threonine KinasesProto-Oncogene ProteinsAURKA protein, humanAurora Kinase ABI 2536cdc25 PhosphatasesCDC2 Protein KinaseCell Cycle ProteinsCyclin BNocodazolePolo-Like Kinase 1Protein Serine-Threonine KinasesProto-Oncogene ProteinsPteridinesRNA, Small InterferingStathminTubulinTubulin Modulators

Identifiers

PMID24152729
PMCPMC3861079
OpenAlexW2151910556

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.